HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-144 Cr | ₹-27 Cr | ₹-7.68 Cr | ₹-5.56 Cr | ₹-97 Cr |
What is the latest Cash Flow from Financing Activities ratio of HIKAL ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-144 Cr |
| Mar2024 | ₹-27 Cr |
| Mar2023 | ₹-7.68 Cr |
| Mar2022 | ₹-5.56 Cr |
| Mar2021 | ₹-97 Cr |
How is Cash Flow from Financing Activities of HIKAL Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-144 Cr | Negative | |
| Mar2024 | ₹-27 Cr | Negative | |
| Mar2023 | ₹-7.68 Cr | Negative | |
| Mar2022 | ₹-5.56 Cr | Negative | |
| Mar2021 | ₹-97 Cr | - | |
Compare Cash Flow from Financing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,046.8 Cr | -3.8% | -17.2% | -56.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -3.8% |
-17.2% |
-56.5% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses